Hydrazonil Cathepsin K Inhibitor Using Trifluoroethylamine as P2-P3 Linking Group and Its Application

A protease inhibitor and cathepsin technology, which is applied in drug combination, organic chemistry, bone diseases, etc., can solve the problems of unfavorable improvement of inhibitor selectivity, poor selectivity, unfavorable combination of inhibitor and enzyme, etc.

Inactive Publication Date: 2017-01-11
JILIN UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this type of inhibitor also has some disadvantages: the selection of inhibitors for Cat K relative to Cathepsin L (Cathepsin L, Cat L), Cathepsin B (Cathepsin B, Cat B) and Cathepsin S (Cathepsin S, Cat S) Low selectivity (about 1-10 times), especially poor selectivity to Cat L
Basic amino groups are prone to form ammonium ions (NH 2 + , ammoniumion), but ammonium ions need to go through desolvation (desolvation) to enter the active site of the enzyme. This process needs to consume part of the binding energy of the inhibitor and the enzyme, which is not good for the combination of the inhibitor and the enzyme. [13]
In addition, alkaline inhibitors have lysosome effect (lysosomotropism), that is, inhibitors tend to be in acidic lysosomes, enrich in lysosomes, and have higher inhibition on non-target enzymes in lysosomes effect, so the inhibitor with strong basicity is not conducive to improving the selectivity of the inhibitor [14]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hydrazonil Cathepsin K Inhibitor Using Trifluoroethylamine as P2-P3 Linking Group and Its Application
  • Hydrazonil Cathepsin K Inhibitor Using Trifluoroethylamine as P2-P3 Linking Group and Its Application
  • Hydrazonil Cathepsin K Inhibitor Using Trifluoroethylamine as P2-P3 Linking Group and Its Application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0070]

[0071] First, 4'-bromo-2,2,2-trifluoroacetophenone (7.59g, 30mmol) and K 2 CO 3 (12.44g, 90mmol) was added to a round bottom flask (capacity 250mL), methanol (20mL) was added to dissolve, and then (6.51g, 36mmol) L-leucine methyl ester salt was added, stirred and refluxed under 50°C water bath for 16h. After this process is finished, the imine derivative b will be generated, and the reaction does not need to be processed again, and is directly used in the next step of the reaction.

[0072] Afterwards, a certain volume of anhydrous acetonitrile (100 mL) was added to the product system obtained in the first step, and the mixture was frozen and evacuated to remove oxygen, and then protected with nitrogen. Slowly add enough Zn(BH 4 ) 2 Tetrahydrofuran solution (2eq, about 0.5M×120mL), after the addition was completed, the reaction was maintained for 3h. After completion, add dilute hydrochloric acid to quench the reaction (add hydrochloric acid to no longer produc...

Embodiment 2

[0074]

[0075] Add c (5.52g, 15mmol) into a round bottom flask (capacity 100mL) filled with THF (20mL), and cool down to -25°C. Add N-methylmorpholine (2.341 mL, 18 mmol) followed by isobutyl chloroformate (1.832 mL, 18 mmol), and the solution will turn white. In addition, 1,2-dimethylhydrazine hydrochloride solution (2.66g, 20mmol, dissolved in 1mL water) and NaOH solution (5M, 8mL) were mixed under ice bath conditions, and the mixed solution was added to the above round bottom flask After 30 min, it was raised to room temperature, and then stirred at room temperature for 90 min. After evaporation to dryness, it was extracted with ethyl acetate (20 mL×4), and the organic phases were combined. Wash with saturated sodium bicarbonate, dilute hydrochloric acid, pure water successively, remove water with anhydrous magnesium sulfate, filter, and evaporate to dryness to obtain a white crude product, which is separated and purified by column chromatography to obtain 4.98g of com...

Embodiment 3

[0081]

[0082] Add d (4.10g, 10mmol) to a round bottom flask (capacity 100mL) filled with methanol (20mL), add sodium acetate (1.64g, 20mmol) and nitrile bromide (2.12g, 20mmol) to it, at room temperature Stir. After 3h, methanol was spin-dried, water (10mL) was added thereto, and KHSO 4 The pH of the solution was adjusted to 1-2. Then it was extracted four times with ethyl acetate (20 mL×4), and the organic phases were combined. The organic solvent was successively washed once with water, twice with saturated sodium bicarbonate and twice with saturated sodium chloride, and then dehydrated with anhydrous magnesium sulfate. After filtering and evaporating to dryness, a white crude product should be obtained, which was separated and purified by silica gel chromatography to obtain 3.27 g of compound 1' with a yield of about 75%.

[0083] Product H NMR, C NMR and mass spectrometry characterization:

[0084] 1 H NMR (500MHz, CDCl 3 ): δ7.51(d, J=8.2Hz, 2H), 7.30(d, J=8.5,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of cathepsin K inhibitors, and particularly relates to novel nitrile cathepsin K inhibitors using cathepsin K as target protein and trifluoroethylamino groups as P2-P3 linkers and having different P3 position structures. The P2-P3 linkers are trifluoroethylamino groups, P3 positions are aryl groups comprising a bromophenyl group, a p-biphenyl group, a p-terphenyl group and a p-methyl biphenyl group. The nitrile inhibitors have the advantages that the structures are simple relatively, the synthesis is convenient, and the yield is high; inhibition constants (Ki) of the compounds (the inhibitors) to cathepsin K are in the picomole level, so that the effective inhibiting ability to the cathepsin K is reflected; when the P3 position is the P-terphenyl group, the inhibiting ability and the selectivity of the inhibitor to the Cat K (the cathepsin K) are better than those of corresponding amide inhibitors. In vitro cytotoxicity tests show that the inhibitors are free of cytotoxicity, and have the possibility of being applied to clinical trials and being used as potential anti-osteoporosis drug.

Description

technical field [0001] The invention belongs to the technical field of cathepsin K inhibitors, in particular to a hydrazinonitrile inhibitor for cathepsin K with trifluoroethylamine as the P2-P3 linking group and different P3-position groups and its use in Application in the preparation of anti-osteoporosis drugs. Background technique [0002] The components of human bones mainly include bone mineral and bone matrix. The bone mineral is mainly hydroxyapatite, and the bone matrix includes type I collagen, osteopontin and osteonectin, among which more than 95% of the bone matrix is ​​composed. Type I collagen is predominant. Skeleton is an important organ of the human body, which has the functions of movement, support and protection of the body. Normal bone metabolism maintains the bone health of the human body, while abnormal bone metabolism brings disease and pain to people. The bone metabolism process is usually regulated by two opposing and unified processes of bone for...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07C261/04A61P19/10
Inventor 吴玉清李洪伟王兴鹏
Owner JILIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products